http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130043627-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c564991ae13d25b7772e76de8d0160e |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4738 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate | 2011-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6935469b980a350f2e569820f6a8aa0f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68de2e6eb8753b346dc7ca38d0b6a204 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e79e0bf7f41ccfc63afad69ecb9cf60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_60c3661e2747447646670727c026027a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c9000ac63a51d59e17fb7d98b40bfc4 |
| publicationDate | 2013-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20130043627-A |
| titleOfInvention | CDCA5 Peptides and Vaccines Including the Same |
| abstract | Isolated peptides derived from SEQ ID NO: 21 and fragments thereof bind HLA antigens and induce cytotoxic T lymphocytes and are therefore suitable for use as cancer immunotherapy, more specifically as cancer vaccines described herein. The creative peptides may be modified by the substitution, deletion, insertion or addition of one, two or some of the amino acids such that the modified amino acid sequence retains the HLA binding and / or CTL inducibility of the original peptide. Include all forms. The present invention also provides nucleic acids encoding the peptides as pharmaceutical agents, substances and compositions comprising or incorporating any of the peptides or nucleic acids. The peptides, nucleic acids, pharmaceutical agents, substances and compositions of the present invention may be used for cancer and tumors, in particular for example acute myeloid leukemia (AML), bladder cancer, breast cancer, cervical cancer ( cervical cancer, cholangiocellular carcinoma, chronic myeloid leukemia (CML), colorectal cancer, esophagus cancer, gastric cancer, gastric diffuse-type cancer It is particularly useful in the treatment of lung cancer, lymphoma, lymphoma, prostate cancer, small cell lung cancer (SCLC) and soft tissue tumors. |
| priorityDate | 2010-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 491.